Log in

NYSEARCA:PJPInvesco Dynamic Pharmaceuticals ETF Stock Price, Forecast & News

$65.52
+0.14 (+0.21 %)
(As of 07/3/2020 04:00 PM ET)
Add
Today's Range
$65.34
Now: $65.52
$66.00
50-Day Range
$61.02
MA: $63.72
$65.56
52-Week Range
$47.14
Now: $65.52
$66.75
Volume29,000 shs
Average Volume35,820 shs
Market Capitalization$360.36 million
P/E RatioN/A
Dividend Yield1.12%
BetaN/A
PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.
Read More

Geographic Exposure of PJP

Currency Exposure of PJP

Sector Exposure of PJP

Industry Exposure of PJP


Basic Details

Issuer Invesco
Fund NameInvesco Dynamic Pharmaceuticals ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:PJP
Inception Date6/23/2005
Fund ManagerPeter Hubbard, Michael Jeanette, Tony Seisser, Jonathan Nixon
Phone+1-800-9830903

Fund Focus

Asset ClassEquity
BenchmarkDynamic Pharmaceuticals Intellidex Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$360.36 million
Average Daily Volume$24,992.60
Discount/Premium0.00%

ETF Expenses

Management Fee0.50%
Other Expenses0.06%
Total Expenses0.56%
Fee Waiver0.00%
Net Expenses0.56%

Administrator, Advisor and Custodian

AdministratorThe Bank of New York Mellon Corporation
AdvisorInvesco Capital Management LLC
CustodianThe Bank of New York Mellon Corporation
DistributorInvesco Distributors, Inc.
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market MakerIMC Chicago

Receive PJP News and Ratings via Email

Sign-up to receive the latest news and ratings for PJP and its competitors with MarketBeat's FREE daily newsletter.

Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP) Frequently Asked Questions

How has Invesco Dynamic Pharmaceuticals ETF's stock been impacted by COVID-19 (Coronavirus)?

Invesco Dynamic Pharmaceuticals ETF's stock was trading at $55.29 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PJP stock has increased by 18.5% and is now trading at $65.52. View which stocks have been most impacted by Coronavirus.

How often does Invesco Dynamic Pharmaceuticals ETF pay dividends? What is the dividend yield for Invesco Dynamic Pharmaceuticals ETF?

Invesco Dynamic Pharmaceuticals ETF declared a quarterly dividend on Monday, December 23rd. Stockholders of record on Tuesday, December 24th will be paid a dividend of $0.1619 per share on Tuesday, December 31st. This represents a $0.65 annualized dividend and a dividend yield of 0.99%. The ex-dividend date is Monday, December 23rd. This is an increase from Invesco Dynamic Pharmaceuticals ETF's previous quarterly dividend of $0.06. View Invesco Dynamic Pharmaceuticals ETF's dividend history.

Has Invesco Dynamic Pharmaceuticals ETF been receiving favorable news coverage?

News headlines about PJP stock have been trending negative recently, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Invesco Dynamic Pharmaceuticals ETF earned a news sentiment score of -2.8 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 7.0 out of 10, meaning that recent news coverage is likely to have an effect on the stock's share price in the near term. View the latest news about Invesco Dynamic Pharmaceuticals ETF.

What other stocks do shareholders of Invesco Dynamic Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invesco Dynamic Pharmaceuticals ETF investors own include Verizon Communications (VZ), iShares Russell 2000 ETF (IWM), iShares 20+ Year Treasury Bond ETF (TLT), Akcea Therapeutics (AKCA), Morgan Stanley (MS), Applied Materials (AMAT), Alibaba Group (BABA), BOX (BOX), Berkshire Hathaway (BRK.B) and Walt Disney (DIS).

Who are Invesco Dynamic Pharmaceuticals ETF's key executives?

Invesco Dynamic Pharmaceuticals ETF's management team includes the following people:
  • H. Bruce Bond, Chairman of the Board of Trustee, Chief Executive Officer (Age 49)
  • Bruce T. Duncan, Chief Financial Officer, Treasurer (Age 60)
  • Kevin R. Gustafson, Chief Compliance Officer (Age 43)
  • Keith A Ovitt, Secretary (Age 50)
  • Ronn R. Bagge, Trustee (Age 55)
  • Marc M Kole, Trustee (Age 53)
  • D. Mark McMillan, Trustee (Age 49)
  • Philip M. Nussbaum Mba, Trustee (Age 52)
  • Donald H. Wilson, Trustee (Age 55)

What is Invesco Dynamic Pharmaceuticals ETF's stock symbol?

Invesco Dynamic Pharmaceuticals ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "PJP."

Who are Invesco Dynamic Pharmaceuticals ETF's major shareholders?

Invesco Dynamic Pharmaceuticals ETF's stock is owned by many different institutional and retail investors. Top institutional shareholders include Advocacy Wealth Management Services LLC (0.62%).

Which institutional investors are buying Invesco Dynamic Pharmaceuticals ETF stock?

PJP stock was bought by a variety of institutional investors in the last quarter, including Advocacy Wealth Management Services LLC.

How do I buy shares of Invesco Dynamic Pharmaceuticals ETF?

Shares of PJP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Invesco Dynamic Pharmaceuticals ETF's stock price today?

One share of PJP stock can currently be purchased for approximately $65.52.

How big of a company is Invesco Dynamic Pharmaceuticals ETF?

Invesco Dynamic Pharmaceuticals ETF has a market capitalization of $360.36 million.

What is Invesco Dynamic Pharmaceuticals ETF's official website?

The official website for Invesco Dynamic Pharmaceuticals ETF is www.invescopowershares.com.

How can I contact Invesco Dynamic Pharmaceuticals ETF?

Invesco Dynamic Pharmaceuticals ETF's mailing address is 301 W. Roosevelt Road, Wheaton, 60187, United States. The company can be reached via phone at +1-800-9830903.

This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.